Neuro-Oncology Faculty Division of Hematology, Oncology, and Blood and Marrow Transplantation

The Division of Hematology, Oncology, and Blood and Marrow Transplantation in the Department of Pediatrics at The Ohio State University located at Nationwide Childrenâ€s Hospital in Columbus, Ohio is seeking a pediatric neuro-oncologist, who is Board Certified in Pediatrics and Board Certified / Eligible in Pediatric Hematology / Oncology to join our Neuro-oncology Program.

Applicants must have completed pediatric neuro-oncology training. Â Interest in developmental therapeutics and / or immunotherapy is preferred.

The Pediatric Neuro-Oncology Program at Nationwide Childrenâ€s Hospital serves children and young adults with CNS tumors with an integrated, multi-disciplinary, and scientific approach including neurosurgery, neurology, endocrinology, neuropathology, neuroradiology, radiation oncology, physical medicine and rehabilitation, palliative care, psychosocial services, fertility preservation, genetics, survivorship, and others.

 In 2023, The Ohio State University in partnership with Nationwide Childrenâ€s Hospital will open the first proton treatment facility in central Ohio.

Nationwide Childrenâ€s Hospital is the home institution for , led by Dr. Maryam Fouladi. The Neuro-Oncology program is also a member of the Childrenâ€s Oncology Group (COG), the Pediatric Brain Tumor Consortium (PBTC), and the Pacific Pediatric Neuro-Oncology Consortium (PNOC).

The team currently includes 4 neuro-oncologists, 4 nurse practitioners, 4 nurse navigators, 2 social workers, and other staff to support the clinical program.

 The Neuro-Oncology Program also offers a one-year pediatric neuro-oncology fellowship training.

The program partners closely with the Steve and Cindy Rasmussen Institute for Genomic Medicine (IGM) at Nationwide Childrenâ€s Hospital and combines a robust clinical laboratory with genome scientists and clinical geneticists to optimize patient care.

 NCH serves as the Biopathology Center to the Childrenâ€s Oncology Group and has 3 pediatric neuropathologists who are an integral part of multi-disciplinary clinical and research efforts of the Neuro-oncology Program.

The IGM and the Biopathology Center are partnering with the National Cancer Institute and the Childrenâ€s Oncology Group in the Molecular Characterization Initiative (MCI), an NCI-funded initiative, to collect, analyze, and report clinical molecular data to support COG-affiliated clinicians in delivering targeted therapies for improved outcomes.

In addition, the Neuro-Oncology Program collaborates actively with Dr. Dean Lee, Director of the Cellular Therapy and Cancer Immunotherapy Program to translate novel immunotherapy approaches to clinical trials for children with high-risk brain tumors.

This position will include clinical service and translational research. Applicants should have strong clinical skills and a commitment to teaching as well as clinical or translational research.

Interest in immunotherapy and development of novel immunotherapy approaches is preferred.

Nationwide Childrenâ€s has a staff of more than 14,000 that provides state-of-the-art wellness, preventive and rehabilitative care and diagnostic treatment during more than million patient visits annually.

As home to the Department of Pediatrics of The Ohio State University College of Medicine, Nationwide Childrenâ€s physicians train the next generation of pediatricians and pediatric specialists.

The Abigail Wexner Research Institute at Nationwide Childrenâ€s Hospital is one of the Top 10 National Institutes of Health-funded free-standing pediatric research facilities.

More information is available at .

To apply, please email a cover letter and CV to :

Maryam Fouladi, MD, MSc, FRCPC

Co-Executive Director of Neuro-Oncology

Elizabeth & Richard Germain Endowed Chair in Pediatric Cancer

Division of Hematology, Oncology & Bone Marrow Transplant

Nationwide Childrenâ€s Hospital

Professor of Pediatrics

The Ohio State University College of Medicine

All inquiries and referrals will remain confidential.